Chimeric Antigen Receptor–Modified T Cells and T Cell–Engaging Bispecific Antibodies: Different Tools for the Same Job

被引：0
作者：
Melanie Schwerdtfeger
Mohamed-Reda Benmebarek
Stefan Endres
Marion Subklewe
Vincenzo Desiderio
Sebastian Kobold
机构：
[1] LMU Munich,Center of Integrated Protein Science Munich (CIPS
[2] University of Campania “Luigi Vanvitelli”,M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München
[3] German Center for Translational Cancer Research (DKTK),Department of Experimental Medicine
[4] German Research Center for Environmental Health (HMGU),Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München
[5] LMU Munich,Department of Medicine III, Klinikum der Universität München
来源：
Current Hematologic Malignancy Reports | 2021年 / 16卷
关键词：
Chimeric antigen receptor; Bispecific antibody; Immunotherapy; Adoptive T cell therapy; T cell redirection; Cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：218 / 233
页数：15
相关论文
共 50 条
  • [21] Chimeric Antigen Receptor T Cells in Hodgkin and T-Cell Lymphomas
    Muhsen, Ibrahim N.
    Hill, LaQuisa C.
    Ramos, Carlos A.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (06) : 1107 - 1124
  • [22] How to train your T cell: genetically engineered chimeric antigen receptor T cells versus bispecific T-cell engagers to target CD19 in B acute lymphoblastic leukemia
    Ruella, Marco
    Gill, Saar
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (06) : 761 - 766
  • [23] Chimeric antigen receptor T-cell therapy in glioblastoma: charging the T cells to fight
    Land, Craig A.
    Musich, Phillip R.
    Haydar, Dalia
    Krenciute, Giedre
    Xie, Qian
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [24] Chimeric antigen receptor-modified T cells strike back
    Frigault, Matthew J.
    Maus, Marcela V.
    INTERNATIONAL IMMUNOLOGY, 2016, 28 (07) : 355 - 363
  • [25] Chimeric antigen receptor T-cell therapy for T-ALL and AML
    Wei, Wenwen
    Yang, Dong
    Chen, Xi
    Liang, Dandan
    Zou, Liqun
    Zhao, Xudong
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [26] Chimeric Antigen Receptor T Cells Targeting Integrin αvβ6 Expressed on Cholangiocarcinoma Cells
    Phanthaphol, Nattaporn
    Somboonpatarakun, Chalermchai
    Suwanchiwasiri, Kwanpirom
    Chieochansin, Thaweesak
    Sujjitjoon, Jatuporn
    Wongkham, Sopit
    Maher, John
    Junking, Mutita
    Yenchitsomanus, Pa-thai
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [27] Chimeric antigen receptor T cell: A cancer immunotherapy
    Singh, Surjit
    Khasbage, Sameer
    Kaur, Rimple Jeet
    Sidhu, Jaspreet Kaur
    Bhandari, Bharti
    INDIAN JOURNAL OF PHARMACOLOGY, 2022, 54 (03) : 226 - 233
  • [28] T-cell Immunotherapy and Cardiovascular Disease Chimeric Antigen Receptor T-cell and Bispecific T-cell Engager Therapies
    Stein-Merlob, Ashley F.
    Ganatra, Sarju
    Yang, Eric H.
    HEART FAILURE CLINICS, 2022, 18 (03) : 443 - 454
  • [29] Mesothelin as a target for chimeric antigen receptor-modified T cells as anticancer therapy
    O'Hara, Mark
    Stashwick, Caitlin
    Haas, Andrew R.
    Tanyi, Janos L.
    IMMUNOTHERAPY, 2016, 8 (04) : 449 - 460
  • [30] Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia
    Yixin Zou
    Wei Xu
    Jianyong Li
    Journal of Hematology & Oncology, 11
12345